Our Cancer Research Grants | V Foundation

The V Foundation’s grant making model ensures the most promising cancer research projects at state-of-the-art facilities around the country are funded.

Cancer research grants are awarded to innovative researchers with the most cutting-edge ideas on how to improve cancer diagnosis methods, prevent cancer recurrences or defeat cancer. 100% of direct donations are used to fund projects we identify as the most likely to help men, women and children diagnosed with cancer.

Featured Grants

Heather Christofk, PhD

Targeting purine salvage dependence in FH-deficient kidney cancer

Alexander Huang, MD

Molecular mechanisms of neoantigen immunosurveillance in Lynch Syndrome

Daniel Wahl, MD, PhD

Measuring and targeting amino acid metabolism in brain cancer

Hemn Mohammadpour, DVM, PhD

Phase I trial of SX-682 a CXCR 1/2 inhibitor in combination with standard o...

Humsa Venkatesh, PhD

Normalizing Dysregulated Neural Circuit Activity for Adult Glioma Treatment

Josephine Taverna, M.D.

AXL-STAT3-PD1 targeting of tumor immune microenvironments

Andrea Cercek, MD

Neoadjuvant Botensilimab and Balstilimab in mismatch-repair proficient rect...

Maria Abreu, MD

Leveraging Microbiome and Metabolomic Strategies to Target DUOX2 Activity f...

Livia Schiavinato Eberlin, PhD

Transforming Cancer Surgery with Medical Mass Spectrometry Technology

Gina Ogilvie, MD

FOCAL MOMENTUM (MicrObiome Monitoring for ElimiNaTion of Cervical Cancer) S...

Gelareh Zadeh, MD, PhD, FRCS(C)

Building Algorithms to Predict Response to Radiation in Meningiomas using T...

Xiao-Nan Li, M.D., Ph.D.

Targeting Root Cells of Therapy Resistance in Pediatric Diffuse High-Grade ...

David Langenau, PhD

Reversing therapy resistance in pediatric rhabdomyosarcoma

Daniel Herranz, PharmD, PhD

Unleashing the therapeutic potential of dietary histidine restriction in T-ALL

Patrick Grohar, MD, PhD

Mechanisms of Resistance for EWS-FLI1 Targeted Therapies

Ashwani Rajput, MD, FACS

Targeted Therapy for BRIDGE DC— Addressing Therapeutic Resistance with Ca...

Marjory Charlot, MD, MPH, MSc

Tailoring Clinical Trial Navigation to Increase Enrollment of Black Patient...

Jiong Li, Ph.D.

FOSL1 degradation overcomes cisplatin resistance in HNSCC

Nadine Barrett, PhD, MA, MS

Understanding and Addressing Cancer Disparities Among American Indians in N...

Omotomilayo Akinyemiju, PhD

Implementing Evidence-Based Interventions to Enhance Equity in Oncology Cli...

Jianguo Tao, PhD

Defining mechanisms of therapy resistance to CDK9 inhibitor (CDK9i) treatme...

Shiri Gur-Cohen, PhD

Decoding Stem Cell-Niche Dependencies in Driving Tumor Evolution and Therap...

Nadine Barrett, PhD, MA, MS

Population Health Navigation: A Comprehensive Intervention to Increase Clin...

Corina Antal, PhD

Uncovering novel post-transcriptional vulnerabilities in pancreatic cancer

Noam Auslander, PhD

Fecal microbial biomarkers of immunotherapy benefit and adverse events in m...

Gina Ogilvie, MD

FOCAL MOMENTUM (MicrObiome Monitoring for ElimiNaTion of Cervical Cancer) S...

Livia Schiavinato Eberlin, PhD

Transforming Cancer Surgery with Medical Mass Spectrometry Technology

Xueqiu (Chu) Lin, PhD

Mapping and modeling oncogenic non-coding networks for colorectal cancer ri...

Maria Abreu, MD

Leveraging Microbiome and Metabolomic Strategies to Target DUOX2 Activity f...

Caroline Bartman, PhD

Targeting vitamin B1 metabolism to starve colorectal cancer

1 2 3 … 85 ▸

Mailing List